Skip to content

Etiology and Prognosis of sICH Based on Hemorrhage Location

Prediction of Etiology and Prognosis Based on Hematoma Location of Spontaneous Intracerebral Hemorrhage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06498778
Enrollment
698
Registered
2024-07-12
Start date
2021-07-01
Completion date
2023-05-31
Last updated
2024-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous Intracerebral Hemorrhage

Keywords

Normative analysis; Lesion-symptom mapping; Radiomics; Etiological classification; Machine learning

Brief summary

The investigators retrospectively collected participants with spontaneous cerebral hemorrhage(sICH) from January 2015 to December 2019 for training and internal validation. Clinical and imaging data were collected. Modified Rankin Scale (mRS) scores were determined good outcome as mRS = 0-2, poor outcome as mRS = 3-6. The location features of sICH were extracted by symptom mapping. Noncontrast computed tomography images of patients and hematoma masks were registered with standard human brain templates to identify specific affected brain regions. Then a probability map of hemorrhage for different causes and prognosis is generated. PyRadiomics was used to extract the radiomic features, integrate radiomic and clinical features into multiple logistic regression models, and develop and validate optimal etiological and prognostic models. Further tests were performed in an independent cohort. The area under the working characteristic curve (AUC), sensibility, specificity were used to evaluate the reliability of the model.

Interventions

None listed

Sponsors

Jinling Hospital, China
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* The confirmation of intracranial hemorrhage was achieved through NCCT.

Exclusion criteria

* They presented with secondary hemorrhage resulting from head trauma, hemorrhagic transformation of ischemic infarction, brain tumors, or exhibited abnormalities in blood coagulation, liver, kidney function, or were subject to drug-induced cerebral hemorrhage * Only postoperative CT images were available * Lost follow-up records * CT image artifacts

Design outcomes

Primary

MeasureTime frameDescription
Modified Rankin Scale (mRS) scoresfollow-ups at twelve months post sICH eventGood outcome as mRS = 0-2, poor outcome as mRS = 3-6

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026